e-ISSN: Pending
Negative / Null Result Report

P074 Significant efficacy and long term safety difference with taf-based str in naïve adults

Jose Arribas; Melanie Thompson; Paul Sax; Edwin DeJesus; Amanda Clark; Moupali Das; Scott McCallister · 2017 · Sexually Transmitted Infections

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract (excerpt)

Introduction At Week(W) 48, elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) was statistically noninferior to E/C/F/tenofovir disoproxil fumarate(TDF) for the proportion of subjects with HIV-1 RNA <50 copies (c)/mL…

Excerpt shown for reference under fair use — read the full paper at the publisher.

Read full paper at publisher

Hosted by the publisher — may require access.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: Crossref · DOI 10.1136/sextrans-2017-053232.119